Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PECS I Block for Breast Augmentation
NCT02849236Completed
- Sponsor
- CHU de Lille
- Start
- Oct 2016
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by CHU de Lille. Primary endpoint: Morphine consumption at 24 hours. Started Oct 2016; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02849236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02849236.